MktsMarkets

Imunon, Inc.
NASDAQ: IMNNKey statistics
IMNN News
Stories mentioning IMNN from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 2,337 | 2,490 | 1,899 | 1,227 | 2,165 | 2,232 | 3,293 | 2,820 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 4,307 | 4,262 | 3,476 | 2,768 | 4,145 | 4,147 | 4,961 | 5,013 |
| Operating Income (Loss) | (4,307) | (4,262) | (3,476) | (2,768) | (4,145) | (4,147) | (4,961) | (5,013) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (4,249) | (4,223) | (3,429) | (2,741) | (4,102) | (4,057) | (4,845) | (4,788) |
| Earnings Per Share (Basic) | (0.84) | (1.99) | (1.16) | (2.15) | (3.15) | (3.69) | (3.76) | (7.64) |
| Earnings Per Share (Diluted) | (0.84) | (1.99) | (1.16) | (2.15) | (3.15) | (3.69) | (3.76) | (7.64) |
| Weighted Average Shares Outstanding (Basic) | 5,029 | 2,123 | 2,944 | 1,277 | 1,301 | 1,099 | 1,290 | 627.00 |
| Weighted Average Shares Outstanding (Diluted) | 5,029 | 2,123 | 2,944 | 1,277 | 1,301 | 1,099 | 1,290 | 627.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About IMNN
Imunon, Inc. (NASDAQ: IMNN) is a stock listed on the Nasdaq Stock Market under the ticker symbol IMNN. It last traded at $0.5400 (Nov 20, 2026, 4:00 PM ET), down 5.2% on the day. That gives Imunon a market capitalisation of $3.6M.
Over the past 52 weeks IMNN has traded between $0.4900 and $4.35.
For the quarter ended Mar 31, 2026 it reported a net loss of $4.2M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$4.2M |
| Dec 31, 2025 | — | -$4.2M |
| Sep 30, 2025 | — | -$3.4M |
| Jun 30, 2025 | — | -$2.7M |
From Imunon’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…